Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma

Jose J G Marin1, Rocio I R Macias1, Candela Cives-Losada1

  • 1HEVEFARM Group, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health. University of Salamanca, IBSAL, 37007-Salamanca, Spain.

Cells
|February 27, 2020
PubMed

Insights

Cholangiocarcinoma (CCA) liver cancer is resistant to chemotherapy due to impaired drug transport. Targeting solute carrier (SLC) and ATP-binding cassette (ABC) transporters offers new strategies to overcome multidrug resistance (MDR) in CCA.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Advanced cholangiocarcinoma (CCA) exhibits extreme resistance to chemotherapy, contributing to poor patient prognosis.
  • Chemoresistance mechanisms in CCA involve impaired drug uptake via solute carrier (SLC) proteins and active drug export by ATP-binding cassette (ABC) proteins.
  • These transport processes reduce intracellular concentrations of chemotherapeutic agents, limiting their efficacy.

Purpose of the Study:

  • To explore the role of the cancer transportome in CCA chemoresistance.
  • To evaluate plasma membrane transporters as potential therapeutic targets for sensitizing CCA to chemotherapy.
  • To assess the utility of differentially expressed transporters as diagnostic and prognostic biomarkers in CCA.

Main Methods:

  • Analysis of the cancer transportome, focusing on solute carrier (SLC) and ATP-binding cassette (ABC) proteins.
  • Investigation of mechanisms regulating drug uptake and export in CCA cells.
  • Evaluation of transporter expression patterns for potential biomarker applications.

Main Results:

  • The cancer transportome, comprising SLC and ABC proteins, is crucial in defining the multidrug resistance (MDR) phenotype of CCA cells.
  • Modulating the expression or function of SLC and ABC transporters presents a strategy to enhance chemotherapy sensitivity.
  • Certain transporters are differentially expressed in CCA, suggesting their potential as diagnostic or prognostic markers.

Conclusions:

  • Targeting the cancer transportome, specifically SLC and ABC transporters, is a promising approach to overcome chemotherapy resistance in cholangiocarcinoma.
  • Understanding transporter roles can lead to novel therapeutic strategies and improved diagnostic/prognostic tools for CCA patients.

Related Concept Videos

The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
40.8K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
916
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
250
Membrane Proteins01:30

Membrane Proteins

Plasma membranes have integral transmembrane proteins involved in facilitated transport. These proteins are collectively referred to as transport proteins, and they function as either channels for the material or as carriers themselves. Channel proteins have hydrophilic domains exposed to the intracellular and extracellular fluids and a hydrophilic channel through their core that provides a hydrated opening for solutes to pass through the membrane layers. Passage through the channel allows...
29.1K
Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
17.5K
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.3K